TOKYO -- Japanese medical device maker Terumo on Wednesday vowed to continue its expansion into new growth fields through mergers and acquisitions after a $1.5 billion deal announced Monday was met with a share price slide.
Health Care
Japan's Terumo justifies $1.5bn organ transplant deal after share slide
Medical device maker aims to diversify with acquisition of Oxford University spinout
Terumo CEO Hikaru Samejima speaks at a press conference on Wednesday. (Photo by Mitsuru Obe)
Read Next
Latest on Health Care
